Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • P260 Real World Data Analysis...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
P260 Real World Data Analysis of Palbociclib plus endocrine therapy in first-line in ibero-american premenopausal women with Luminal Advanced Breast Cancer

P260 Real World Data Analysis of Palbociclib plus endocrine therapy in first-line in ibero-american premenopausal women with Luminal Advanced Breast Cancer

Bibliographic Details
Main Authors: J.C. Samame, M.V. Costanzo, A. Gasol, A. Ostinelli, O. Rua, R. Motta, V. Failoc, S. Falcón, S. Morales
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977623003788
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:1532-3080

Similar Items

  • Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy
    by: Colombo GL, et al.
    Published: (2023-03-01)
  • Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer
    by: Soohyeon Lee, et al.
    Published: (2022-04-01)
  • Endocrine issues and premenopausal breast cancer
    by: Mara Carsote, et al.
    Published: (2021-12-01)
  • Absolute lymphocyte count predicts efficacy of palbociclib in patients with metastatic luminal breast cancer
    by: Takayuki Kobayashi, et al.
    Published: (2024-09-01)
  • Cost-effectiveness Analysis of Ribociclib plus Letrozole versus Palbociclib plus Letrozole in the United Kingdom
    by: Gaurav Suri, et al.
    Published: (2019-04-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs